Use of benzodiazepines and related drugs is associated with a risk of stroke among persons with Alzheimer’s disease
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
The aim of our study was to investigate the risk of any, ischemic, and hemorrhagic stroke associated with incident benzodiazepine and related drug (BZDR) use among community-dwelling individuals with Alzheimer's disease (AD). Data from the MEDALZ cohort including all community-dwelling persons newly diagnosed with AD between 2005 and 2011 in Finland were utilized. Incident BZDR users were identified with a 1-year washout period for previous use. Persons with a previous stroke were excluded, resulting in a final study sample of 45 050 individuals. Incident any, ischemic, and hemorrhagic strokes were identified from the Hospital Discharge and Causes of Death registers. The risk of stroke between time on BZDRs was compared with nonuse time with Cox proportional hazard models. During the follow-up, 21.9% (N=9879) of persons started BZDR use. Compared with nonuse, BZDR use was associated with an increased risk of any stroke [adjusted hazard ratio (aHR): 1.21; 95% confidence interval (CI): 1.04-1.40] and ischemic stroke (aHR: 1.21; 95% CI: 1.02-1.44), but the association between BZDR use and hemorrhagic stroke did not reach significance (aHR: 1.26; 95% CI: 0.91-1.74). Z-drug use was associated with a similar risk as benzodiazepine use. In conclusion, BZDR use was associated with an increased risk of stroke among older individuals with AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quality of the Finnish Hospital Discharge Register: A systematic review
Sund, R. (2012) · Scandinavian Journal of Public Health · doi:10.1177/1403494812456637 · Cited by 1,185
Self-citationCognitive Effects of Long-Term Benzodiazepine Use: A Meta-Analysis
Barker, M. J., Greenwood, K. M., Jackson, M., & Crowe, S. F. (2004) · CNS Drugs · doi:10.2165/00023210-200418010-00004 · Cited by 552
Wang, P. S., Bohn, R. L., Glynn, R. J., Mogun, H., & Avorn, J. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.6.892 · Cited by 312
Dell’osso, B., & Lader, M. (2013) · European Psychiatry · doi:10.1016/j.eurpsy.2011.11.003 · Cited by 210 · cited 5×
“BZDs present potential for abuse, rebound effects, and dependence (Dell’osso and Lader, 2013).”
BackgroundInfluentialFourrier, A., Letenneur, L., Dartigues, J., Moore, N., & Bégaud, B. (2001) · European Journal of Clinical Pharmacology · doi:10.1007/s002280100326 · Cited by 158 · cited 1×
“Community-dwelling older individuals frequently use benzodiazepines and related drugs (BZDRs), previous studies reporting a point prevalence up to 31% (Fourrier et al., 2001; Linjakumpu et al., 2002; Carrasco-Garrido et al., 2007).”
Background
Cited by
Ralph, S. J., & Espinet, A. J. (2018) · Journal of Alzheimer's Disease Reports · doi:10.3233/adr-170042 · Cited by 160
EAN/ERS/ESO/ESRS statement on the impact of sleep disorders on risk and outcome of stroke
Bassetti, C. L. A., Randerath, W., Vignatelli, L., Ferini-Strambi, L., Brill, A.-K., Bonsignore, M. R., Grote, L., Jennum, P., Leys, D., Minnerup, J., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.01104-2019 · Cited by 132
EAN/ERS/ESO/ESRS statement on the impact of sleep disorders on risk and outcome of stroke
Bassetti, C. L. A., Randerath, W., Vignatelli, L., Ferini‐Strambi, L., Brill, A. ‐., Bonsignore, M. R., Grote, L., Jennum, P., Leys, D., Minnerup, J., et al. (2020) · European Journal of Neurology · doi:10.1111/ene.14201 · Cited by 109
“[99] investigated the risk of ischaemic, haemorrhagic or any stroke associated with incident BDZR use in 45 050 community-dwelling individuals with Alzheimer’s disease.”
BackgroundRichardson, K., Loke, Y. K., Fox, C., Maidment, I., Howard, R., Steel, N., Arthur, A., Boyd, P. J., Aldus, C., Ballard, C., et al. (2020) · BMC Medicine · doi:10.1186/s12916-020-01821-5 · Cited by 73
Metadata
- Authors
- Taipale, H., Koponen, M., Tanskanen, A., Lavikainen, P., Tolppanen, A.-M., Sund, R., Tiihonen, J., & Hartikainen, S.
- Venue
- International Clinical Psychopharmacology
- Published
- 2017-05
- Volume
- 32
- Issue
- 3
- Pages
- 135-141
- ISSN
- 0268-1315 (ISSN-L)
- OpenAlex
- W2570214341
- Cited by
- 27
- References
- 5
- FWCI
- 2.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Use of benzodiazepines and related drugs is associated with a risk of stroke among persons with Alzheimer’s disease. https://app.cochat.ai/papers/10.1097/yic.0000000000000161
- The paper
- Taipale, H., Koponen, M., Tanskanen, A., Lavikainen, P., Tolppanen, A.-M., Sund, R., Tiihonen, J., & Hartikainen, S. (2017). Use of benzodiazepines and related drugs is associated with a risk of stroke among persons with Alzheimer’s disease. International Clinical Psychopharmacology. https://doi.org/10.1097/yic.0000000000000161
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.